Press Releases

Year 2010 |Year 2009 | Year 2008 | Year 2007 | Year 2006 | Year 2005 | Year 2004

• December 11, 2009
  Welichem Begins Patient Enrollment for Phase IIb Trial of WBI-1001 Creams in Patients with Atopic Dermatitis (A Common Type of Eczema) More...
  
  
• November 17, 2009
  Welichem announces 2009 AGM Board members election and management changes More...
  
  
• September 30, 2009
  Welichem Announces Filing of Phase II Multi-centre Clinical Trial Application More...
  
  
• September 29, 2009
  Welichem Filed Annual Report Ended May 31, 2009 More...
  
  
• September 15, 2009
  Welichem closes private placement More...
  
  
• July 08, 2009
  Welichem to Effect Share Consolidation and Raise $3.75 Million in Non-Brokered Private Placement More...
  
  
• April 20, 2009
  Welichem announces IND-enabling toxicology studies for its lead drug, WBI-1001 More...
  
  
• April 08, 2009
  Welichem announces special meeting results More...
  
  
• March 12, 2009
  Wenfeng Liu and York Ying Ping Guo Resign as Directors More...
  
  
• March 10, 2009
  Welichem Proposes Share Consolidation More...
  
  
• Janurany 26, 2009
  Welichem Reports Successful pre-CTA Meeting with Health Canada More...
  
  
• Janurany 09, 2009
  Welichem Announces Appointment of New CFO More...